Sven Wagner
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Genetics top 10%
- Immunology
- Co-authors
- K. RoosenSiglinde KerkauGiles H. VinceJörg C. TonnPeter RieckmannRoland GoldbrunnerHakim BouterfaJoerg‐Christian Tonn
- Topics
- Protease and Inhibitor Mechanisms (6 papers)Angiogenesis and VEGF in Cancer (4 papers)Signaling Pathways in Disease (3 papers)
- Partner nations
- GermanyNepalUnited States
In The Last Decade
Sven Wagner
12 papers receiving 620 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 306
- Cancer Research 208
- Oncology 177
- Genetics 133
- Immunology 127
Countries citing papers authored by Sven Wagner
This map shows the geographic impact of Sven Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Wagner more than expected).
Fields of papers citing papers by Sven Wagner
This network shows the impact of papers produced by Sven Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Wagner. The network helps show where Sven Wagner may publish in the future.
Co-authorship network of co-authors of Sven Wagner
This figure shows the co-authorship network connecting the top 25 collaborators of Sven Wagner. A scholar is included among the top collaborators of Sven Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Wagner. Sven Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 20 | |
| 3 | Urokinase plasminogen activator, uPAR, MMP-2, and MMP-9 in the C6-glioblastoma rat model. | 14 |
| 4 | 26 | |
| 5 | 85 | |
| 6 | 47 | |
| 7 | 116 | |
| 8 | 126 | |
| 9 | 10 | |
| 10 | 50 | |
| 11 | 88 | |
| 12 | 35 |
About Sven Wagner
Sven Wagner is a scholar working on Cancer Research, Neurology and Immunology and Allergy, having authored 12 papers that have together received 627 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Signaling Pathways in Disease (3 papers). The work is most often cited by research in Immunology and Allergy (100 citations), Cancer Research (208 citations) and Genetics (133 citations). Sven Wagner has collaborated with scholars based in Germany, Nepal and United States. Frequent co-authors include K. Roosen, Siglinde Kerkau, Giles H. Vince, Jörg C. Tonn, Peter Rieckmann, Roland Goldbrunner, Hakim Bouterfa, Joerg‐Christian Tonn, J. C. Tonn and Wolfgang Roggendorf. Their work appears in journals such as The FASEB Journal, FEBS Letters and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.